Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
98 EUR | -1.01% |
|
-.--% | +2.08% |
06-21 | Amylyx to buy bankrupt Eiger's experimental drug to treat low blood sugar | RE |
06-21 | Weight-loss drug Zepbound resolves sleep apnea in up to 52% of patients, Lilly says | RE |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ELI LILLY AND COMPANY | Other Pharmaceuticals | -1.01% | -.--% | - | - | - | 798B | - | - | - |
Technical Rankings Surperformance
- Stock Market
- Equities
- LLY Stock
- LLY Stock
- Charts Eli Lilly and Company
- Comparison Chart